针对表皮生长因子受体III型突变体靶向治疗肿瘤的研究进展
摘要
表皮生长因子受体III型突变体(EGFRvIII)在许多类型肿瘤的发生发展中具有重要作用,它仅表达于肿瘤细胞,而正常细胞不表达,因此成为肿瘤治疗的理想靶点。现对EGFRvIII在肿瘤研究中的进展作一综述。
出处
《现代肿瘤医学》
CAS
2007年第4期557-560,共4页
Journal of Modern Oncology
基金
国家自然科学基金项目(编号:30600744)
参考文献25
-
1Sihto H,Puputti M,Pulli L,et al.Epidermal growth factor receptor domain Ⅱ,Ⅳ,and kinase domain mutations in human solid tumors[J].J Mol Med,2005,83(12):976 ～983.
-
2Moscatello DK,Holgado-Madruga M,Emlet DR,et al.Constitutive activation of phosphatidylinositol 3-kinase by a natureally occurring mutant epidermal growth factor receptor[J].J Biol Chem,1998,273(1):200 ～206.
-
3Ramnarain DB,Park S,Lee DY,et al.Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells[J].Cancer Res,2006,66(2):867 ～874.
-
4Pedersen MW,Tkach V,Pedersen N,et al.Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility[J].Int.J Cancer,2004,108 (5):643 ～ 653.
-
5Ning Y,Zeineldin R,Liu Y,et al.Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvⅢ) induces aberrant cell spreading and focal adhesion formation[J].Cancer Res,2005,65 (20):9280 ～ 9286.
-
6Li B,Yuan M,Kim IA,et al.Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin[J].Oncogene,2004,23(26):4594 ～4602.
-
7Heimberger AB,Hlatky R,Suki D,et al.Prognostic effect of epidermal growth factor receptor and EGFRvⅢ in glioblastoma multiforme patients[J].Clin Cancer Res,2005,11 (4):1462 ～ 1466.
-
8Montgomery RB.Antagonistic and agonistic effects of quinazoline tyrosine kinase inhibitors on mutant EGF receptor function[J].Int J Cancer,2002,101 (2):111 ～ 117.
-
9Moscatello DK,Holgado-Madruga M,Emlet DR,et al.Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor[J].J Biol Chem,1998,273 (1):200 ～ 206.
-
10Sampson JH,Crotty LE,Lee S,et al.Unarmed,tumor-specific monoclonal antibody effectively treats brain tumors[J].Proc Natl Acad Sci U S A,2000,97(13):7503 ～7508.
-
1刘英姿,杨慧敏,梁鲁彪.EGFRvⅢ、MMP-2在子宫内膜癌中的表达及其临床意义[J].华夏医学,2015,28(5):1-4. 被引量：1
-
2朱彦红,李修岭.表皮生长因子受体Ⅲ型突变体在胃癌的表达及其临床意义[J].中国实用医刊,2011,38(10):11-12.
-
3李雨弥,徐卫云.表皮生长因子受体Ⅲ型突变体靶向治疗乳腺肿瘤的研究进展[J].中华乳腺病杂志（电子版）,2011,5(1):48-51.
-
4樊平,邹赛英,赵海华.EGFR和EGFRvⅢ在胃癌中的表达及意义[J].现代生物医学进展,2009,9(16):3112-3114. 被引量：3
-
5吴飞翔,赵荫农,罗元,曹骥,苏建家,陈军.EGFR、EGFRvⅢ在肝细胞癌中的表达及意义[J].广西医科大学学报,2005,22(6):853-855.
-
6石玉生,谭燕,伍锡栋,张兴梅.c-Met siRNA对U87-EGFRvⅢ胶质瘤细胞凋亡和增殖的影响[J].实用医学杂志,2013,29(6):854-856. 被引量：1
-
7段小艺,王健生,张明鑫,夏鹏.人肾透明细胞癌中EGFRvⅢ的表达及意义[J].西安交通大学学报（医学版）,2008,29(4):441-442. 被引量：6
-
8朱彦红,韩大正.表皮生长因子受体及其Ⅲ型突变体在人食管癌的表达及意义[J].中国现代医学杂志,2016,26(7):24-28. 被引量：2
-
9孙平风,傅芬.表皮生长因子受体Ⅲ型突变体在卵巢癌中检测及靶向治疗的研究进展[J].基础医学与临床,2015,35(11):1567-1571. 被引量：2
-
10颜红莲,章龙珍.表皮生长因子受体Ⅲ型突变体与恶性胶质瘤靶向治疗[J].国际肿瘤学杂志,2012,39(3):200-202.
